Open AccessCoronary heart disease and chronic kidney disease: the possibilities of PCSK9 inhibitors in the achievement of atherogenic lipoproteins target values
Author(s) -
Г. С. Маль,
A. A. Kuznetsov
Publication year - 2022
Publication title -
innovacionnaâ medicina kubani
Language(s) - English
Resource type - Journals
eISSN - 2541-9897
pISSN - 2500-0268
DOI - 10.35401/2541-9897-2022-25-2-14-21
Subject(s) - medicine , kidney disease , renal function , atorvastatin , pcsk9 , cholesterol , ezetimibe , cardiology , coronary heart disease , ldl cholesterol , endocrinology , urology , lipoprotein , gastroenterology , ldl receptor